Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects

NCT03392116 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
92
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NGM Biopharmaceuticals, Inc